Genetron Holdings Limited stock is down -0.26% since 30 days ago. The next earnings date is Mar 5, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 February’s closed higher than January.
Genetron Holdings Limited engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early liver cancer screening services. It also provides in-vitro diagnostic products, including 8-gene lung cancer assay.
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!